Talaris Therapeutics, Inc. (TALS) has 20 open-market insider trades by 6 insiders since 2021. The most active filer is Suzanne Ildstad, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Sandip Agarwala | Dir10% Owner | — | 1 | $4.0M | 2021-05-11 |
| Suzanne Ildstad | Dir | — | 13 | $2.7M | 2023-06-14 |
| Blackstone Holdings II L.P. | 10% Owner | — | 1 | $510K | 2021-05-11 |
| Francois Nader | Dir | — | 1 | $500K | 2022-07-25 |
| Scott Requadt | CEO | — | 3 | $407K | 2023-07-03 |
| Clarus Defined Exit I, L.P. | 10% Owner | — | 1 | $118K | 2021-05-11 |
| Longitude Capital Partners III, LLC | 10% Owner | — | 0 | — | 2021-05-11 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Suzanne Ildstad | Director | Sell | $112K | 2023-06-12 |
| Suzanne Ildstad | Director | Sell | $685K | 2023-06-07 |
| Suzanne Ildstad | Director | Sell | $149K | 2023-06-05 |
| Suzanne Ildstad | Director | Sell | $80K | 2023-06-01 |
| Suzanne Ildstad | Director | Sell | $35K | 2023-04-21 |
| Suzanne Ildstad | Director | Sell | $266K | 2023-04-19 |
Companies that share insiders with TALS, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Suzanne Ildstad | Director | Sell | $639K | 2023-04-17 |
| Suzanne Ildstad | Director | Sell | $21K | 2023-03-17 |
| Suzanne Ildstad | Director | Sell | $14K | 2023-03-03 |
| Suzanne Ildstad | Director | Sell | $59 | 2023-03-01 |
| Suzanne Ildstad | Director | Sell | $7K | 2023-02-21 |
| Suzanne Ildstad | Director | Sell | $13K | 2023-02-16 |
| Suzanne Ildstad | CSO | Sell | $1.5M | 2022-08-22 |
| Scott Requadt | CEO | Buy | $335K | 2022-07-29 |
| Scott Requadt | CEO | Buy | $37K | 2022-07-26 |